Skip to main content

Events & Presentations

2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF)

June 5th, 2026 - Royal Sonesta New Orleans

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

Platform Technologies Panel: Obesity & Cardiovascular-Kidney-Metabolic Disease Kevin Slawin, M.D., Founder and CEO Eos SENOLYTIX Dr. Slawin will also give a 20-minute presentation in Track B that begins at 1:45...

The 17th World Congress on Targeting Mitochondria 2026

October 21st to 23rd, Berlin

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

Dr. Slawin’s address, “Building on the Foundation of Four: Advancing Mitochondrial‑Targeted Geropeptide Medicine” will directly follow Dr. Hazel H. Szeto’s historic keynote address, “From Mitochondrial Discovery to Approved Therapy: Lessons…

Vitalist Bay – Lighthaven, Berkeley

May 14th-17th 2026 - Lighthaven, Berkeley CA

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

Vitalist Bay Deep Dive Pitches May 15th, 2026 05:30PM to 06:30PM Vitalist Bay – Longevity’s New Capital  

SENOTHERAPEUTICS SUMMIT 2025

September 16 - 19, 2025, Rome, Italy

Presenter: Kevin Slawin, M.D., Founder and CEO, Eos SENOLYTIX

Phaedon Institute is honored to co-host the 2nd Senotherapeutics Summit alongside the 10th Annual ICSA Conference. This landmark gathering will take place September 16th–19th at the prestigious National Research Council (CNR) in Rome, Italy. Bringing…